- ►sbinfecto.org.br [PDF] A Carr, DA Cooper - The Lancet, 2000 - Elsevier Several factors have combined to increase our attention on the toxicity of
HAART. First, since HIV-1 eradication seems unlikely with current therapy, 1 and
2 HAART will need to be indefinite for clinical benefits to be preserved. ... Cited by 696 - Related articles - BL Direct - All 11 versions
- ►ucsf.edu [PDF] MS Sulkowski, DL Thomas, RE Chaisson, RD … - Jama, 2000 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 652 - Related articles - BL Direct - All 9 versions
SG Deeks, T Wrin, T Liegler, R Hoh, M … - The New England journal of medicine, 2001 - nejm.highwire.org Results Discontinuation of therapy for 12 weeks was associated with a median
decrease in the CD4 cell count of 128 cells per cubic millimeter and an increase
in the plasma HIV RNA level of 0.84 log copies per milliliter. Virus from ... Cited by 610 - Related articles - BL Direct - All 6 versions
DR Bangsberg, FM Hecht, ED Charlebois, AR … - Aids, 2000 - journals.lww.com From the a Epidemiology and Prevention Interventions (EPI) Center, Division of
Infectious Diseases, and b Positive Health Program, San Francisco General
Hospital, University of California San Francisco, San Francisco, CA, USA ... Cited by 593 - Related articles - All 5 versions
A Mocroft, B Ledergerber, C Katlama, O Kirk, … - The Lancet, 2003 - Elsevier The incidence of AIDS or death fell after September, 1998, by 8% per 6–month
period (rate ratio 0·92, 95% CI 0·88–0·95, p<0·0001). When AIDS and death
were analysed separately, the incidence of all deaths during the late-HAART ... Cited by 518 - Related articles - All 8 versions
- ►ajph.org [PDF] RS Janssen, DR Holtgrave, RO Valdiserri, M … - American Journal of Public Health, 2001 - Am Public Health Assoc In the United States, HIV preven- tion programs have historically tailored
activities for specific groups primarily on the basis of behavioral risk factors
and demographic characteristics. Through the Serostatus Approach to ... Cited by 376 - Related articles - BL Direct - All 5 versions
B Ramratnam, JE Mittler, L Zhang, D Boden, … - Nature Medicine, 2000 - nature.com Replication-competent HIV-1 can be isolated from infected patients despite
prolonged plasma virus suppression by anti-retroviral treatment 1, 2, 3 . Recent
studies have identified resting, memory CD4 + T lymphocytes as a long-lived ... Cited by 332 - Related articles - BL Direct - All 2 versions
- ►yale.edu [PDF] KA Freedberg, E Losina, MC Weinstein, AD … - The New England journal of medicine, 2001 - nejm.highwire.org Methods We developed a mathematical simulation model of HIV disease, using the
CD4 cell count and HIV RNA level as predictors of the progression of disease.
Outcome measures included life expectancy, life expectancy adjusted for the ... Cited by 314 - Related articles - BL Direct - All 12 versions
DR Bangsberg, S Perry, ED Charlebois, RA … - Aids, 2001 - journals.lww.com Three hundred and thirty HIV-positive individuals were recruited into the
Research in Access to Care in the Homeless (REACH) cohort between July 1996 and
April 2000. We performed adherence assessments in 76 of the 81 (94%) ... Cited by 292 - Related articles - BL Direct - All 3 versions
- ►pnas.org JM Strizki, S Xu, NE Wagner, L Wojcik, J … - Proceedings of the National Academy of Sciences, 2001 - National Acad Sciences We describe here the identification and properties of SCH-C (SCH 351125), a
small molecule inhibitor of HIV-1 entry via the CCR5 coreceptor. SCH-C, an
oxime–piperidine compound, is a specific CCR5 antagonist as determined in ... Cited by 272 - Related articles - BL Direct - All 11 versions
